Advertisement
News
Subscribe to MDT Magazine News

AACR Applauds Appointment of Ellen V. Sigal, Ph.D., to the Patient-Centered Outcomes Research Institute Board of Governors

September 24, 2010 3:33 pm | by AACR | Comments

WASHINGTON, D.C. — The American Association for Cancer Research applauds the appointment of Ellen V. Sigal, Ph.D., chairperson and founder of the Friends of Cancer Research, to the board of governors for the new Patient-Centered Outcomes Research Institute (PCORI).

TOPICS:

AACR President-elect Testifies Before President’s Cancer Panel

September 24, 2010 3:31 pm | by AACR | Comments

WASHINGTON, D.C. — AACR President-elect Judy E. Garber, M.D., M.P.H., testified on Sept. 22 before the President's Cancer Panel, "The Future of Cancer Research: Accelerating Scientific Innovation." The panel is exploring progress achieved since the National Cancer Act of 1971, and...

TOPICS:

Health insurer rule draft yields few surprises

September 24, 2010 12:45 pm | by The Associated Press | Comments

The framework for a key health care reform rule governing insurance companies wound up falling mostly in line with Wall Street expectations, according to a Leerink Swann analyst.A draft of the rule for medical loss ratios was released Thursday by the National Association of Insurance...

Advertisement

MLSC appoints Borisy, Fuchs, Nelsen to science board

September 24, 2010 12:33 pm | by Mass High Tech: The Journal of New England Technology | Comments

The Massachusetts Life Sciences Center has appointed three new members to its scientific advisory board, including Gary Borisy of the Marine Biological Laboratory, Rainer Fuchs of Biogen Idec Innovation Incubator, and Lita Nelsen of the MIT technology licensing office.

Electric Dental Handpieces and Electric Oral Bone-cutting Handpieces: Safety Investigation of Patient Burns

September 24, 2010 12:33 pm | by U.S. Food & Drug Administration | Comments

Device overheating may result in serious 1st to 3rd degree patient burns.

Sanofi-aventis, Dana-Farber enter cancer therapeutics deal

September 24, 2010 11:34 am | by Mass High Tech: The Journal of New England Technology | Comments

French drug giant Sanofi-aventis has entered into a collaboration deal with Dana-Farber Cancer Institute's Belfer Institute of Applied Cancer Science that will bring $33 million to the institute.

MLSC appoints Borisy, Fuchs, Nelson to science board

September 24, 2010 11:33 am | by Mass High Tech: The Journal of New England Technology | Comments

The Massachusetts Life Sciences Center has appointed three new members to its scientific advisory board, including Gary Borisy of the Marine Biological Laboratory, Rainer Fuchs of Biogen Idec Innovation Incubator, and Lita Nelsen of the MIT technology licensing office.

Medical Device Safety Tip: Resectoscopes for Infants and Babies

September 24, 2010 7:31 am | by U.S. Food & Drug Administration | Comments

During cystoscopy and incision of a ureterocele in a 2-month old, the insulation slipped off the sheath and slid over the tip of the catheter exposing the hook electrode. Fortunately, the 2-month old was not injured. It was discovered that improper...

TOPICS:
Advertisement

Medical Device Safety Tip: Aesculap AVM Micro Clip(2)

September 24, 2010 7:31 am | by U.S. Food & Drug Administration | Comments

FDA received a report about three AVM Micro Clips that were accidentally implanted in a patient prior to being sterilized. The patient was placed on prophylactic IV antibiotics after the error was discovered and was to be scheduled for an imaging study...

TOPICS:

Medical Device Safety Tip: Aesculap AVM Micro Clip

September 24, 2010 7:30 am | Comments

FDA received a report about three AVM Micro Clips that were accidentally implanted in a patient prior to being sterilized. The patient was placed on prophylactic IV antibiotics after the error was discovered and was to be scheduled for an imaging study...

Unprecedented effort to seek, test and treat inmates with HIV

September 24, 2010 6:35 am | by EurekAlert | Comments

(NIH/National Institute on Drug Abuse) Twelve scientific teams in more than a dozen states will receive National Institutes of Health grants to study effective ways to prevent and treat HIV/AIDS among people in the criminal justice system.

TOPICS:

Symposium in Washington with world-leading scientists

September 24, 2010 6:35 am | by EurekAlert | Comments

(Karolinska Institutet) The Nobel Prize, the correlation between genes and lifestyle, and the ability of the brain to repair itself are three of the topics that will be discussed at an international symposium today at the Swedish embassy, the House of Sweden, in Washington, D.C....

TOPICS:

Novartis deal over, Alnylam plans layoffs

September 24, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge RNAi-focused biotech Alnylam Pharmaceuticals Inc. is planning to cut up to 30 percent of its workforce as the company completes the last year of a five-year alliance with Novartis that is expected to bring milestone payments to the company.

Results From Argos Therapeutics' Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidne...

September 24, 2010 6:33 am | by Bio-Medicine.Org | Comments

DURHAM, N.C., Sept. 24 /- Argos Therapeutics today announced that results from its Arcelis™ immunotherapy Phase 2 study for the treatment of renal cell carcinoma (RCC) have been accepted for a poster presentation at the Ninth International Kidney Cancer Symposium on Oct. 1-2 in...

TOPICS:

Perrigo Confirms Filing for Omeprazole/Sodium Bicarbonate and Announcement of Patent Infringement Lawsuit by Schering-Plough Healthcare Products

September 24, 2010 6:32 am | by Bio-Medicine.Org | Comments

ALLEGAN, Mich., Sept. 24 /- Perrigo Company (Nasdaq: PRGO ; TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for omeprazole 20mg/sodium bicarbonate 1100mg, the generic equivalent of Zegerid OTC™, and that...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading